Profusa, Inc. Common Stock (PFSA) Stock Analysis & Investment Frameworks
Profusa, Inc. Common Stock (PFSA) stock analysis on Invetso. Review Profusa, Inc. Common Stock’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Profusa, Inc. Common Stock Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Profusa, Inc. Common Stock Key Financial Metrics
- Market Cap: $4.34M
- Revenue: $N/A
- ROE: 148.25%
- ROIC: 242.59%
- Dividend Yield: N/A
About Profusa, Inc. Common Stock
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Profusa, Inc. Common Stock Investment Frameworks
Invetso analyzes Profusa, Inc. Common Stock (PFSA) across the following frameworks:
- Profusa, Inc. Common Stock 10Y Growth Potential
- Profusa, Inc. Common Stock Scenario Analysis
- Profusa, Inc. Common Stock Risks & Opportunities
- Profusa, Inc. Common Stock Economic Moat
- Profusa, Inc. Common Stock Business Model
- Profusa, Inc. Common Stock Management
- Profusa, Inc. Common Stock SWOT Analysis
- Profusa, Inc. Common Stock Porter's 5 Forces
- Profusa, Inc. Common Stock PESTLE Analysis
- Profusa, Inc. Common Stock ESG Analysis